Lucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays
29 sept. 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health” or “Lucira”), a medical technology company, today announced interim results of a pilot...
Lucira Health to Participate in LifeSci Partners HealthTech Symposium
07 sept. 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of...
Lucira Health to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
23 août 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of...
Lucira Health Announces Second Quarter 2022 Results and Provides Business Updates
15 août 2022 16h01 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and...
Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test
11 août 2022 07h01 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and...
Lucira Health to Announce Second Quarter 2022 Financial Results
02 août 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of...
Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 août 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization...
Lucira Health Announces First Quarter 2022 Results and Business Update
12 mai 2022 16h01 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and...
Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test
12 mai 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization...
Lucira Receives CE Mark for both COVID-19 & Flu and COVID-19 Molecular Tests
09 mai 2022 08h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization...